Europe investments
Print page

Our Investments

All of our European investments are listed below in greater detail.  The majority of our investments are expansion-stage life science and technology companies in the Nordic region.

Cellectricon

Registered Office:

Göteborg, SWEDEN

Listed:

Unlisted

Business Area:

Private Equity Investments

Geographic Market:

Europe

Sector:

Pharma

Subsector:

Life Science Tools

Investment Year:

2002

Serving On The Board:

Karl Swartling

About Cellectricon

Cellectricon develops and sells platforms for cell-based drug discovery based on unique competences in microfabrication, microfluidics, biosensors and cell biology. Live cellular analysis enables researchers to monitor drug candidate efficacy on a real-time basis as the drug enters the cell and alters its function. Cellectricon’s first products are used today by the vast majority of the leading players in the pharmaceutical industry.

For more information visit www.cellectricon.se

 

Information updated 2008-07-29 07:25:57

 
  

© Investor AB, Arsenalsgatan 8C, SE-103 32 Stockholm, Sweden. Telephone: +46 8 614 20 00 | Investor mobile web | Cookies

This website is not intended to offer or to promote the offer or sale of Investor AB securities in the United States or to U. S. persons